Drug Profile
LAS 101057
Alternative Names: LAS101057Latest Information Update: 20 Mar 2008
Price :
$50
*
At a glance
- Originator Laboratorios Almirall
- Class
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 02 Aug 2007 Phase-I clinical trials in Asthma in Europe (unspecified route)